UNSPSC 51152109: Belladonna/phenobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA802. This VA Drug Class (GA802) classifies this compound as belonging to the group ANTIMUSCARINIC/ANTIPASMODIC COMBINATIONS.

UNSPSC 51152109 Belladonna/phenobarbital, a Commodity code, shows minimal recent state and local activity aligned with its nominal pharmaceutical scope. The two recent opportunities tagged to this code involve naloxone/drug deactivation systems and direct-to-manufacturer pharmacy benefit programs — neither of which is belladonna or phenobarbital. The code does not reflect actual procurement of the specific drug compounds named; state and local buyers appear to tag broad pharmaceutical or pharmacy-management activity to this code without regard to the specific active ingredient. Issuing bodies using the code include county health departments and state health and human services agencies.

Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note: date discrepancy in source). The Texas Health and Human Services Commission issued an RFI (HHS0017013) on April 3, 2026, to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and wholesaler channels. Both solicitations address opioid response and pharmacy program management rather than belladonna/phenobarbital specifically. The code shows activity in Florida and Texas, but the mismatch between the code's nominal scope and the actual work being procured suggests this Commodity code either receives sporadic or misclassified tagging in state and local systems, making it an unreliable signal for pursuing vendors in the belladonna/phenobarbital market.